Microbot Medical Inc. Files 8-K for Material Agreement and Officer Changes
Ticker: MBOT · Form: 8-K · Filed: Feb 7, 2025 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Feb 7, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, officer-changes, director-changes
TL;DR
Microbot Medical inked a big deal & shook up execs/board. Big changes coming.
AI Summary
Microbot Medical Inc. announced on February 5, 2025, a material definitive agreement and changes in its board and officer compensation. The company, incorporated in Delaware, filed its 8-K report on February 7, 2025, detailing these events. The filing also includes financial statements and exhibits.
Why It Matters
This 8-K filing signals significant corporate actions, including a new material agreement and potential shifts in executive compensation or board structure, which could impact the company's strategic direction and investor outlook.
Risk Assessment
Risk Level: medium — The filing indicates material definitive agreements and changes in officers/directors, which can introduce uncertainty and potential strategic shifts.
Key Players & Entities
- Microbot Medical Inc. (company) — Registrant
- February 5, 2025 (date) — Earliest event reported
- February 7, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the nature of the material definitive agreement entered into by Microbot Medical Inc.?
The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
What specific changes occurred regarding directors or officers?
The filing notes the departure of directors or certain officers, the election of directors, and the appointment of certain officers, along with compensatory arrangements, but specific names and details are not in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 5, 2025.
What is the filing date of this 8-K report?
This 8-K report was filed on February 7, 2025.
What are the key items disclosed in this 8-K filing?
The key items disclosed are the entry into a material definitive agreement, departure of directors or certain officers, election of directors, appointment of certain officers, and financial statements and exhibits.
Filing Stats: 679 words · 3 min read · ~2 pages · Grade level 11.7 · Accepted 2025-02-07 16:30:13
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex10-1.htm (EX-10.1) — 25KB
- ex10-2.htm (EX-10.2) — 26KB
- ex10-3.htm (EX-10.3) — 18KB
- ex10-1_001.jpg (GRAPHIC) — 4KB
- ex10-1_002.jpg (GRAPHIC) — 4KB
- ex10-2_001.jpg (GRAPHIC) — 5KB
- ex10-2_002.jpg (GRAPHIC) — 11KB
- 0001493152-25-005410.txt ( ) — 327KB
- mbot-20250205.xsd (EX-101.SCH) — 3KB
- mbot-20250205_lab.xml (EX-101.LAB) — 33KB
- mbot-20250205_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: February 7, 2025